Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Koniku
AddedFeb 15, 2024
UpdatedJun 18, 2026
Koniku

Koniku

Series A

Berkeley-based Koniku Inc. pioneers in synthetic biology, producing neuron-integrated 'wetchips'.

HQ
San Rafael, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Koniku Inc., based in Berkeley, CA, is a synthetic biology company that integrates biological neurons with silicon to create "wetchips." These advanced microchips, also known as smell cyborgs, are designed to detect and map volatile organic compounds, aiming to revolutionize health diagnostics and wellness by enabling real-time disease detection and health monitoring. Koniku envisions a future where these devices are ubiquitous in homes, empowering individuals to manage their health proactively.

Koniku has made significant strides in the field of synthetic biology, blending biological and technological innovation to create practical health solutions. The company's pioneering work in neuron-integrated microchips has positioned it as a leader in the emerging market of real-time health diagnostics. By focusing on the integration of biological systems with silicon technology, Koniku is set to make a substantial impact on personal health management and disease prevention.

Koniku - Similar Companies

Neuro-Kinesis logo

Neuro-Kinesis

SiPhox Health logo

SiPhox Health

siphox.com

Uchu Biosensors logo

Uchu Biosensors

Diagnostic Biochips logo

Diagnostic Biochips

Vocxi Health logo

Vocxi Health

Chronus Health logo

Chronus Health

chronushealth.com

Ontera logo

Ontera

ontera.bio

Newomics logo

Newomics

newomics.com

SiPhox Health logo

SiPhox Health

siphoxhealth.com

Bioniq Health logo

Bioniq Health

Nephrosant logo

Nephrosant

Persperion Diagnostics logo

Persperion Diagnostics

persperiontech.com

BioSens8 logo

BioSens8

biosens8.com

Kineolabs logo

Kineolabs

kineolabs.com

Clinicai logo

Clinicai

Koniku - Quick Facts

Who are Koniku's competitors?

Companies similar to Koniku include Neuro-Kinesis, SiPhox Health, Uchu Biosensors and Diagnostic Biochips.

When was Koniku founded?

Koniku was founded in 2015.

Where is Koniku's headquarters located?

Koniku's headquarters is located in San Rafael, CA, US.

When was Koniku's last funding round?

Koniku's most recent funding round was for $37M (USD) in December 2021.

How much has Koniku raised to-date?

As of Dec 17, 2021, Koniku has raised a total of $49.2M (USD).

How many employees does Koniku have?

Koniku has 11 employees as of Feb 5, 2024.

Koniku - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Biotech
  • Sensors
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Health Diagnostics
  • Wetchips
Tags
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 6 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7371Computer Programming Services